Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bright light and melatonin in demented elderly residents
NL-OMON28032Active, not recruiting
- Start
- Jun 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of melatonin in Dementia, sleep disorder and circadian rhythm sleep disorder (CRSD) (4 arms). Primary endpoints: Rest-activity rhythm, Salivary melatonin rhythm and 8 more. Started Jun 1999; status: active, not recruiting.
02
Drugs
melatonin
03
Conditions
Dementiasleep disordercircadian rhythm sleep disorder (CRSD)
Beyond the preview
Go deeper on NL-OMON28032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28032.